Table 4.
Medications prescribed at discharge
| Whole population (N=2962), N (%) | NSTEMI (N=1275), N (%) | STEMI or presumed new LBBB (N=1687), N (%) | p Value | |
| Aspirin | 2841 (96) | 1203 (94) | 1638 (97) | <0.001 |
| Clopidogrel | 1852 (62) | 872 (68) | 980 (58) | <0.001 |
| Prasugrel | 798 (27) | 206 (16) | 592 (35) | <0.001 |
| Dual antiplatelet therapy | 2576 (87) | 1039 (81) | 1537 (91) | <0.001 |
| Statin | 2699 (91) | 1134 (89) | 1565 (93) | <0.001 |
| Beta-blocker | 2547 (86) | 1045 (82) | 1502 (89) | <0.001 |
| ACE-I or ARB | 2361 (80) | 949 (74) | 1412 (84) | <0.001 |
CABG, coronary artery bypass graft surgery; CAD, coronary artery disease; GRACE, Global registry of acute coronary events; LBBB, left bundle branch block; MI, myocardial infarction; NSTEMI, non-ST-segment-elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment-elevation myocardial infarction; TIA, transient ischaemic attack.